Histopathological Subtypes of Cutaneous Melanoma: Prognostic and Molecular Implications

Cutaneous melanoma is a biologically diverse and clinically aggressive malignancy with distinct histopathological subtypes that significantly influence its diagnosis, prognosis, and management. This comprehensive review explores the major melanoma subtypes, superficial spreading, nodular, lentigo maligna, acral lentiginous, and desmoplastic melanoma, along with rarer variants such as spitzoid, nevoid, and mucosal melanomas. Each subtype exhibits unique morphological characteristics, growth patterns, anatomical distribution, and molecular profiles, including variations in key mutations such as B-Raf proto-oncogene, serine/threonine kinase (BRAF), KIT proto-oncogene receptor tyrosine kinase (KIT), Neuroblastoma RAS viral oncogene homolog (NRAS), and Neurofibromin 1 (NF1). While histologic subtype is not incorporated into formal staging systems, it frequently correlates with tumor behavior and patient outcomes, guiding surgical planning and adjuvant therapy decisions. Advances in immunohistochemistry, molecular diagnostics, and genomic profiling have refined melanoma classification and opened new avenues for targeted and immune-based therapies. However, diagnostic challenges persist due to overlapping features and under-characterization of rare variants. This review underscores the need for a multimodal approach that integrates histopathologic, molecular, and clinical data to achieve precise classification and optimize patient care in the era of personalized oncology.